ReNeuron Group plc (LON:RENE – Get Free Report)’s share price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 3.38 ($0.04) and traded as high as GBX 3.50 ($0.04). ReNeuron Group shares last traded at GBX 3.38 ($0.04), with a volume of 177,373 shares trading hands.
ReNeuron Group Stock Performance
The firm has a market capitalization of £1.93 million, a PE ratio of -37.50 and a beta of 0.69. The company has a debt-to-equity ratio of 14.25, a current ratio of 1.51 and a quick ratio of 2.02. The firm has a fifty day moving average price of GBX 3.38 and a 200 day moving average price of GBX 4.21.
About ReNeuron Group
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease.
Further Reading
- Five stocks we like better than ReNeuron Group
- Trading Halts Explained
- Comprehensive PepsiCo Stock Analysis
- What Are Dividend Challengers?
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What is Put Option Volume?
- Bear Market Funds to Watch This Year
Receive News & Ratings for ReNeuron Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReNeuron Group and related companies with MarketBeat.com's FREE daily email newsletter.
